• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Cancer Organoids Offer Insights into Treatment Outcomes

      Cancer Organoids Offer Insights into Treatment Outcomes

      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Laser-Based Breath Analysis Detects COVID-19 Infection

      Laser-Based Breath Analysis Detects COVID-19 Infection

      Technique Reveals 3D Genome Interactions

      Technique Reveals 3D Genome Interactions

    • Radiology
      Implanted Ultrasound Lets Chemo Access Brain

      Implanted Ultrasound Lets Chemo Access Brain

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

      RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

    • Cardiology
      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Chest Wearable Provides Key Heart Measurements

      Chest Wearable Provides Key Heart Measurements

      Vein on a Chip Includes Flexible Valves

      Vein on a Chip Includes Flexible Valves

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

    • Surgery
      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Stimulating Wounds with Electricity for Rapid Healing

      Stimulating Wounds with Electricity for Rapid Healing

    • Nanomedicine
      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Fluorouracil (5FU) Market 2027 Recent Trends, Growth Opportunities, Forecast by Application and Types with Worldwide Top Key Players- Nantong Haier’s Pharmaceutical, Jinghua Pharmaceutical, DCS Pharma AG, Glaxo Smith Kline Pharmaceuticals, Dabur Pharmaceuticals, Taj Pharmaceuticals, and Dolder

November 5th, 2020 Coherent Market Insights Releases

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Fluorouracil is an antimetabolite and pyrimidine chemical compound which is effectively used in treatment of cancer throughout the world. According to the World Health Organization’s list of essential medicines, fluorouracil is the most effective and safest drug for treatment of cancer. Fluorouracil is given systemically for treating anal, breast, stomach, and pancreatic cancers and administered topically in the treatment of Bowen’s disease and skin cancer. According to the International Medicinal Product Price Guide, the wholesale cost of fluorouracil in developing countries is between US$ 1.18 to US$ 3.40 per 500 mg vial.

Request FREE Sample

Global Fluorouracil (5FU) Market – Drivers

The rising prevalence of non-communicable diseases such as cancer is major burden. Fluorouracil is the most potent and effective first line drug treatment for cancer. Thus pharmaceutical companies are investing in research and development activities which is expected to support growth of this market. For instance, in 2016, Shire plc announced that the European Commission has granted approval to ONIVYDE for treatment of metastatic adenocarcinoma of pancreas in combination with 5-fluorouracil and leucovorin in treatment of adults. Moreover, in 2019, Accord Healthcare announced that they have launched a fluorouracil injection in Australia. These factors are expected to drive the global fluorouracil market growth.

Global Fluorouracil (5FU) Market – Impact of COVID-19

Since the outbreak of COVID-19 in 2019, the disease has spread throughout the world and hampered growth of several markets across the globe. The growth of the global fluorouracil market is expected to get hampered, According to National Cancer Institute United States, some cancer treatment such as chemotherapy can lower immune system in cancer patient and may increase risk of COVID-19 in cancer patients. Whereas fluorouracil is first line chemotherapy drug used for treatment of cancer patients. Thus may increase risk for cancer patient of getting infected by COVID-19. Nationwide lockdown in several countries across the globe has led to a reduction in production capacity of pharmaceutical companies due to less manpower. Moreover, the pandemic has directly affected production and demand of products across the global market. Moreover, it has also disrupted the supply chain in the market as a result of lockdowns across the globe.

Read Research Report: https://www.coherentmarketinsights.com/ongoing-insight/fluorouracil-5fu-market-4246

Global Fluorouracil (5FU) Market – Restraints

Side effects of 5-Fluorouracil include gastrointestinal dysfunction and enteric neurotoxicity in majority of the patients. Moreover, high cost of drugs for treatment of skin cancer is also restraining the market growth. For instance, the cost of 5–fluorouracil topical cream 0.5 is around US$ 1,253 for 30 gm in the U.S. These factors are expected to restrain the global fluorouracil market growth.

Global Fluorouracil (5FU) Market – Regional Analysis

On the basis of region, the global fluorouracil market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. In North America, the burden of cancer and uncommunicable disease is on the rise since the last decade. For instance, according to NIH-National Cancer Institute, in 2018 was estimated that 1,735,350 new cases of cancer were diagnosed in United States. Various initiatives have been taken by governments as well as non-government organizations. For instance, Pan America Health Organization (PAHO) is working in North America to reduce premature deaths caused by cancer to 25% by 2030. Moreover, there has been an increase in research and development in the past decade. For instance, in 2016, the University of Michigan Rogel Cancer Center completed its study on Gemcitabine, Infusional 5–Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers.

Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/4246

According to the World Health Organization (WHO), in 2012 cancer accounts for more than 3.7 million new cases and 1.9 million deaths each year in Europe, and therefore cancer is the second leading cause of deaths and morbidity in Europe. Therefore, pharmaceutical companies are focusing on research and development of newer conjugate therapies using fluorouracil. In 2019, at the World Conference on Lung Cancer, Ipsen a pharmaceutical company in France, develops medicines in oncology and rare disease and Servier an international pharmaceutical company in France, announced safety and efficiency data from phase 2 and Resilient study of ONIVYDE in patients with lung cancer, which led the U.S. Food Drug Administration and European Medicine agency to approve ONIVYDE in combination with fluorouracil/leucovorin for treating pancreatic cancer.

Global Fluorouracil (5FU) Market – Competitive analysis

Key players operating in global fluorouracil (5FU) market are Nantong Haier’s Pharmaceutical co. ltd, Jinghua Pharmaceutical Co., Ltd, DCS Pharma AG, Glaxo Smith Kline Pharmaceuticals Ltd, Dabur Pharmaceuticals Ltd, Taj Pharmaceuticals Limited, and Dolder Ltd.

Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/4246

Key Developments–

  1. In June 2020, the U.S. Food Drug and Administration approved Keytruda (Merck) with fluorouracil, leucovorin and oxaliplatin as a first line drug treatment for colorectal cancer.
  2. In 2016, the University of Health, Toronto, completed its clinical trial of Abraxane and Cisplatin and 5–fluorouracil as inductory chemotherapy treatment in head and neck cancer.

Global Fluorouracil (5FU) Market – Taxonomy

  • By Product Type –
    • Injectable
    • Capsules
    • Tablets
  • By Route of Administration –
    • Parental
    • Oral
    • Others
  • By Indication –
    • Colon and Rectal Cancer
    • Anal Cancer
    • Breast Cancer
    • Gastrointestinal Cancer
    • Head and Neck Cancer
    • Thymic Cancer
    • Others
  • By Region –
    • North America
    • Latent America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa

Other Exclusive Reports:

Esophageal Cancer Drugs Market, By Therapy Type (Chemotherapy (Docetaxel, Irinotecan, Trifluridine and Tipiracil, Carboplatin and Paclitaxel, Cisplatin and 5-fluorouracil, and Cisplatin with Capecitabine), Targeted Drug Therapy (Trastuzumab and Ramucirumab), and Immunotherapy (Pembrolizumab)), By Disease Indication (Adenocarcinomas, Gastrointestinal Stromal Tumors, Carcinoid Tumors, Squamous Cell Carcinoma, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share Outlook, and Opportunity Analysis 2019 – 2027

Stomach Cancer Drugs Market, By Therapy Type (Kinase Inhibitors, Nucleoside Metabolic Inhibitors, Anthracyclines, Microtubule Inhibitors, VEGF Antibodies, HER2 Receptor Antagonists, Car T Cell Therapy), By Application (Adenocarcinomas, Gastrointestinal Stromal Tumors, and Carcinoid Tumors), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share Outlook, and Opportunity Analysis, 2019 – 2026

Colon and Rectal Cancer Drugs Market, By Drug Type (Single Drug (Colon Cancer (Cetuximab, Bevacizumab, Avastin, Capecitabine, Nivolumab, Panitumumab, Oxaliplatin, and Others), Rectal Cancer (Avastin, Capecitabine, Erbitux, Cyramza, Irinotecan Hydrochloride, Nivolumab, and Others)), Combination Drug (Colon Cancer (CAPOX, FOLFOX, FOLFIRI, FOLFIRI-CETUXIMAB, XELIRI, and Others), Rectal Cancer (FU-LV, CAPOX, FOLFIRI-BEVACIZUMAB, XELOX, XELIRI, and Others))), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Geography – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Sign up and submit a press release

Sponsored

Packaging Compliance Labs (PCL) Celebrates Site Expansion in Grand Rapids, MI

Novel Approach to Assessing Lung Function Enables Improved Detection, Diagnosis and Treatment Decisions in Subject Exposed to Military Burn Pits

U.S. Patent Office Grants Additional Patent Protection For  Exoskeleton Focal-Force Angioplasty Platform

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

interviews & reviews
Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email